129-134
Editorial
The strange case of TGN1412
L. Farzaneh, N. Kasahara and F. Farzaneh
135-146
Original Article
Analysis of naïve and memory CD4 and CD8 T cell populations in breast cancer patients receiving a HER2/
neu
peptide (E75) and GM-CSF vaccine
Matthew T. Hueman, Alexander Stojadinovic, Catherine E. Storrer, Zia A. Dehqanzada and Jennifer M. Gurney, et al.
147-154
Original Article
Endowing self-binding feature restores the activities of a loss-of-function chimerized anti-GM2 antibody
Yunfeng Zhao, Michael Russ, Marc Retter, Gary Fanger and Charles Morgan, et al.
155-163
Original Article
In vivo tracking of macrophage activated killer cells to sites of metastatic ovarian carcinoma
D. Ritchie, L. Mileshkin, D. Wall, J. Bartholeyns and M. Thompson, et al.
165-180
Original Article
Immunotherapy success in prophylaxis cannot predict therapy: prime-boost vaccination against the 5T4 oncofoetal antigen
Sumia Ali, Kate Mulryan, Taher Taher and Peter L. Stern
181-192
Original Article
Induction of an effective anti-tumor immune response and tumor regression by combined administration of IL-18 and Apoptin
Hai Lian, Ningyi Jin, Xiao Li, Zhiqiang Mi and Jingmin Zhang, et al.
193-204
Original Article
Retinoic acid elicits cytostatic, cytotoxic and immunomodulatory effects on uveal melanoma cells
Simona Vertuani, Eugenia Dubrovska, Victor Levitsky, Martine J. Jager and Rolf Kiessling, et al.
205-215
Original Article
Human interleukin 24 (MDA-7/IL-24) protein kills breast cancer cells via the IL-20 receptor and is antagonized by IL-10
Mingzhong Zheng, Dora Bocangel, Blair Doneske, Abner Mhashilkar and Rajagopal Ramesh, et al.
217-226
Original Article
Preventive and therapeutic vaccination with PAP-3, a novel human prostate cancer peptide, inhibits carcinoma development in HLA transgenic mice
Arthur Machlenkin, Ronit Azriel-Rosenfeld, Ilan Volovitz, Ezra Vadai and Avital Lev, et al.
227-236
Original Article
Immune selective pressure and HLA class I antigen defects in malignant lesions
Chien-Chung Chang and Soldano Ferrone
237-248
Original Article
Low-dose cyclophosphamide modulates galectin-1 expression and function in an experimental rat lymphoma model
Mariano F. Zacarías Fluck, María J. Rico, Silvia I. Gervasoni, Juan M. Ilarregui and Marta A. Toscano, et al.
249-258
Original Article
Melanocyte differentiation antigen RAB38/NY-MEL-1 induces frequent antibody responses exclusively in melanoma patients
Alfred Zippelius, Asma Gati, Tammo Bartnick, Senta Walton and Bernhard Odermatt, et al.
259-269
Original Article
Lack of tumor recognition by cytolytic T lymphocyte clones recognizing peptide 195–203 encoded by gene MAGE-A3 and presented by HLA-A24 molecules
Tomoko So, Takeshi Hanagiri, Jacques Chapiro, Didier Colau and Francis Brasseur, et al.